Libby P, Buring JE, Badimon L, Hansson GK, Deanfield J, Bittencourt MS, et al. Atherosclerosis. Nat Rev Dis Primers. 2019;5(1): 56. https://doi.org/10.1038/s41572-019-0106-z.
Bjorkegren JLM, Lusis AJ. Atherosclerosis: Recent developments. Cell. 2022;185(10):1630–45. https://doi.org/10.1016/j.cell.2022.04.004.
Article CAS PubMed PubMed Central Google Scholar
Gonzalez AL, Dungan MM, Smart CD, Madhur MS, Doran AC. Inflammation resolution in the cardiovascular system: arterial hypertension, atherosclerosis, and ischemic heart disease. Antioxid Redox Signal. 2024;40(4–6):292–316. https://doi.org/10.1089/ars.2023.0284.
Article CAS PubMed PubMed Central Google Scholar
Back M, Yurdagul A Jr, Tabas I, Oorni K, Kovanen PT. Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities. Nat Rev Cardiol. 2019;16(7):389–406. https://doi.org/10.1038/s41569-019-0169-2.
Article PubMed PubMed Central Google Scholar
Stroope C, Nettersheim FS, Coon B, Finney AC, Schwartz MA, Ley K, et al. Dysregulated cellular metabolism in atherosclerosis: mediators and therapeutic opportunities. Nat Metab. 2024;6(4):617–38. https://doi.org/10.1038/s42255-024-01015-w.
Article PubMed PubMed Central Google Scholar
Doran AC, Yurdagul A Jr, Tabas I. Efferocytosis in health and disease. Nat Rev Immunol. 2020;20(4):254–67. https://doi.org/10.1038/s41577-019-0240-6.
Article CAS PubMed Google Scholar
Adkar SS, Leeper NJ. Efferocytosis in atherosclerosis. Nat Rev Cardiol. 2024;21(11):762–79. https://doi.org/10.1038/s41569-024-01037-7.
Schilperoort M, Ngai D, Sukka SR, Avrampou K, Shi H, Tabas I. The role of efferocytosis-fueled macrophage metabolism in the resolution of inflammation. Immunol Rev. 2023;319(1):65–80. https://doi.org/10.1111/imr.13214.
Article CAS PubMed PubMed Central Google Scholar
Moore KJ, Tabas I. Macrophages in the pathogenesis of atherosclerosis. Cell. 2011;145(3):341–55. https://doi.org/10.1016/j.cell.2011.04.005.
Article CAS PubMed PubMed Central Google Scholar
Doran AC. Inflammation resolution: implications for atherosclerosis. Circ Res. 2022;130(1):130–48. https://doi.org/10.1161/CIRCRESAHA.121.319822.
Article CAS PubMed PubMed Central Google Scholar
Kumar D, Pandit R, Yurdagul A Jr. Mechanisms of continual efferocytosis by macrophages and its role in mitigating atherosclerosis. Immunometabolism. 2023;5(1): e00017. https://doi.org/10.1097/IN9.0000000000000017.
Yurdagul A Jr. Crosstalk between macrophages and vascular smooth muscle cells in atherosclerotic plaque stability. Arterioscler Thromb Vasc Biol. 2022;42(4):372–80. https://doi.org/10.1161/ATVBAHA.121.316233.
Schilperoort M, Ngai D, Katerelos M, Power DA, Tabas I. PFKFB2-mediated glycolysis promotes lactate-driven continual efferocytosis by macrophages. Nat Metab. 2023;5(3):431–44. https://doi.org/10.1038/s42255-023-00736-8.
Article CAS PubMed PubMed Central Google Scholar
Tabas I, Bornfeldt KE. Intracellular and intercellular aspects of macrophage immunometabolism in atherosclerosis. Circ Res. 2020;126(9):1209–27. https://doi.org/10.1161/CIRCRESAHA.119.315939.
Article CAS PubMed PubMed Central Google Scholar
Seeley EH, Liu Z, Yuan S, Stroope C, Cockerham E, Rashdan NA, et al. Spatially resolved metabolites in stable and unstable human atherosclerotic plaques identified by mass spectrometry imaging. Arterioscler Thromb Vasc Biol. 2023;43(9):1626–35. https://doi.org/10.1161/ATVBAHA.122.318684.
Article CAS PubMed PubMed Central Google Scholar
Gastanadui MG, Margaroli C, Litovsky S, Richter RP, Wang D, Xing D, et al. Spatial transcriptomic approach to understanding coronary atherosclerotic plaque stability. Arterioscler Thromb Vasc Biol. 2024;44(11):e264-76. https://doi.org/10.1161/ATVBAHA.123.320330.
Article CAS PubMed Google Scholar
Sun J, Singh P, Shami A, Kluza E, Pan M, Djordjevic D, et al. Spatial transcriptional mapping reveals site-specific pathways underlying human atherosclerotic plaque rupture. J Am Coll Cardiol. 2023;81(23):2213–27. https://doi.org/10.1016/j.jacc.2023.04.008.
Article CAS PubMed Google Scholar
Willemsen L, de Winther MP. Macrophage subsets in atherosclerosis as defined by single-cell technologies. J Pathol. 2020;250(5):705–14. https://doi.org/10.1002/path.5392.
Article PubMed PubMed Central Google Scholar
Steinberg D, Witztum JL. Oxidized low-density lipoprotein and atherosclerosis. Arterioscler Thromb Vasc Biol. 2010;30(12):2311–6. https://doi.org/10.1161/ATVBAHA.108.179697.
Article CAS PubMed Google Scholar
Poznyak AV, Nikiforov NG, Markin AM, Kashirskikh DA, Myasoedova VA, Gerasimova EV, et al. Overview of OxLDL and Its Impact on Cardiovascular Health: Focus on Atherosclerosis. Front Pharmacol. 2020;11: 613780. https://doi.org/10.3389/fphar.2020.613780.
Article CAS PubMed Google Scholar
Yurdagul A Jr, Green J, Albert P, McInnis MC, Mazar AP, Orr AW. alpha5beta1 integrin signaling mediates oxidized low-density lipoprotein-induced inflammation and early atherosclerosis. Arterioscler Thromb Vasc Biol. 2014;34(7):1362–73. https://doi.org/10.1161/ATVBAHA.114.303863.
Article CAS PubMed PubMed Central Google Scholar
Yurdagul A Jr, Sulzmaier FJ, Chen XL, Pattillo CB, Schlaepfer DD, Orr AW. Oxidized LDL induces FAK-dependent RSK signaling to drive NF-kappaB activation and VCAM-1 expression. J Cell Sci. 2016;129(8):1580–91. https://doi.org/10.1242/jcs.182097.
Article CAS PubMed PubMed Central Google Scholar
Duewell P, Kono H, Rayner KJ, Sirois CM, Vladimer G, Bauernfeind FG, et al. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature. 2010;464(7293):1357–61. https://doi.org/10.1038/nature08938.
Article CAS PubMed PubMed Central Google Scholar
Raines EW. The extracellular matrix can regulate vascular cell migration, proliferation, and survival: relationships to vascular disease. Int J Exp Pathol. 2000;81(3):173–82. https://doi.org/10.1046/j.1365-2613.2000.00155.x.
Article CAS PubMed PubMed Central Google Scholar
Hernandez GE, Ma F, Martinez G, Firozabadi NB, Salvador J, Juang LJ, et al. Aortic intimal resident macrophages are essential for maintenance of the non-thrombogenic intravascular state. Nat Cardiovasc Res. 2022;1(1):67–84. https://doi.org/10.1038/s44161-021-00006-4.
Article CAS PubMed PubMed Central Google Scholar
Chen R, Zhang H, Tang B, Luo Y, Yang Y, Zhong X, et al. Macrophages in cardiovascular diseases: molecular mechanisms and therapeutic targets. Signal Transduct Target Ther. 2024;9(1): 130. https://doi.org/10.1038/s41392-024-01840-1.
Article PubMed PubMed Central Google Scholar
Satish M, Agrawal DK. Atherothrombosis and the NLRP3 inflammasome - endogenous mechanisms of inhibition. Transl Res. 2020;215:75–85. https://doi.org/10.1016/j.trsl.2019.08.003.
Comments (0)